Hard to find info. But I did find this from Reuters.
https://af.reuters.com/article/metalsNews/idAFFWN1P202M
Bit of a summary of Ann from Reuters there so nothing you can’t find In the Ann. Canntab website doesn’t reveal too much but Emblem who they’ve aligned others have seen their sp drop by 43% recently which if you consider just how well pot stocks have been performing that pretty significant.
https://www.investopedia.com/investing/10-canadian-marijuana-stocks/
To me this deal is very early days but the fact that vitacann has to fork out 100% of first million of expenses tells me it’s a better deal for canntab than Vitacann.
Also I don’t buy the bs that these are the only guys that do a slow release pill with the only pharma grade cannabis. So far QBL don’t have the ability to grow anything but low thc hemp, algae tec are waiting for there’s as well. This has to go through testing and approvals and be prescribed by a doctor and once it has been given the all clear vitahemp have to pay first $1000000 of expenses..
Might make the sp jump but there’s a long way to go yet before you see these pills.
Anyway good luck! Just my take! I’d be pulling profits before jan quarterly or before a credit raising is due.